A case report of complete remission of acute myeloid leukemia combined with <i>DNMT3A, FLT3-TKD</i>, and <i>IDH2</i> gene mutations and active pulmonary tuberculosis treated with homeharringtonine + venetoclax + azacytidine. This evidence concerns the gene DNMT3A and pulmonary tuberculosis.